TWI368523B
(en )
2012-07-21
Pharmaceutical compositions comprising imatinib and a release retardant
HK1244267A1
(en )
2018-08-03
Pharmaceutical compositions comprising (r)-n-methylnaltrexone
EP1945197A4
(en )
2010-08-11
Stabilized extended release pharmaceutical compositions comprising a beta-adrenoreceptor antagonist
ZA200801158B
(en )
2009-08-26
Sustained drug release composition
ZA200705530B
(en )
2008-10-29
Sustained release pharmaceutical formulations
GB0409703D0
(en )
2004-06-02
Pharmaceutical compositions
EP2056835A4
(en )
2013-01-30
Pharmaceutical compositions and uses thereof
HK1121950A1
(en )
2009-05-08
Stable pharmaceutical composition comprising a pyrimidine-sulfamide
GB0408308D0
(en )
2004-05-19
Pharmaceutical compositions
EP1885665A4
(en )
2012-05-02
Dithiocarbamates and phosphite formulations
IL188352A0
(en )
2008-04-13
Pharmaceutical compositions
EP1802346A4
(en )
2011-07-06
Sustained release pharmaceutical composition
ZA200804103B
(en )
2009-10-28
Pharmaceutical compositions
EP1805154A4
(en )
2009-11-25
Pharmaceutical compositions
GB0522045D0
(en )
2005-12-07
Pharmaceutical compositions
EP1871348A4
(en )
2012-08-01
Sustained release pharmaceutical compositions
IL192091A0
(en )
2008-12-29
Pharmaceutical compositions
IL186337A0
(en )
2008-01-20
Stannsoporfin compositions and administration
ZA200709692B
(en )
2008-11-26
Antineoplastic compounds and pharmaceutical compositions thereof
EP1937292A4
(en )
2010-02-03
Lopap-based pharmaceutical compositions and uses thereof
EP1901718A4
(en )
2012-07-18
Modified release ticlopidine compositions
EP1845944A4
(en )
2011-07-27
Pharmaceutical compositions
EP1809298A4
(en )
2008-06-18
Neuroprotective spirostenol pharmaceutical compositions
EP1865777A4
(en )
2008-07-16
Stannsoporfin compositions and administration
SI1888040T1
(en )
2010-12-31
Pharmaceutical compositions comprising imatinib and a release retardant